Nosocomial pneumonia

Critical Care Nursing Quarterly

Volumn 27, Issue 3, 2004, Pages 241-257

  Myrianthefs, Pavlos M ^a,b   Kalafati, Maria ^a   Samara, Irini ^a   Baltopoulos, George J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Diagnosis; Epidemiology; Management; Nosocomial pneumonia; Pathogenesis; Prevention; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; GLYCOPEPTIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CLINICAL FEATURE; COMA; DIAGNOSTIC ACCURACY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAND WASHING; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LONG TERM CARE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NOSOCOMIAL PNEUMONIA; OROPHARYNX; PATHOGENESIS; PNEUMONIA; PRESCRIPTION; RESPIRATORY SYSTEM; RESPIRATORY TRACT INTUBATION; REVIEW; RISK FACTOR; STOMACH; STRESS ULCER; SUPINE POSITION; SURVIVAL; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 3242724036     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200407000-00005     Document Type: Review

References (91)

1. Osler W. The Principles and Practice of Medicine. 7th ed. New York: D Appleton and Co; 1909.
2. Johanson WG, Dever LL. Nosocomial pneumonia. Intensive Care Med. 2003;29:23-29.
3. Mehta RM, Michael S, Niederman MS. Nosocomial pneumonia. Curr Opin Infect Dis. 2002;15:387-394.
4. Lode H, Raffenberg M, Erbes R, Geerdes-Fengea H, Mauch M. Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment and prevention. Curr Opin Infect Dis. 2000;13:377-384.
5. Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in US hospitals, 1975-76: estimated frequency by selected characteristics of patients. Am J Med. 1981;70:947-959.
6. Ewig S, Bauer T, Torres A. The pulmonary physician in critical care 4: nosocomial pneumonia. Thorax. 2002;57:366-371.
7. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society. Am J Respir Crit Care Med. 1996;153:1711-1725.
8. Rello J, Ausina V, Castella J, et al. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy. Chest. 1992;102:525-529.
9. Ewig S, Torres A, El-Ebiary M, et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med. 1999;159:188-198.
10. Akca O, Koltka K, Uzel S, et al. Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus non-resistant bacteria. Anesthesiology. 2000;93:638-645.
11. Sirvent JM, Torres A, Vidaur L, et al. Tracheal colonization within 24 h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Med. 2000;26:1369-1372.
12. Trouillet JL, Chastre J, Vugnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998; 157:531-539.
13. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study; EPIC International Advisory Committee. JAMA. 1995;274:639-644.
14. Spencer RC. Epidemiology of infections in ICUs. Intensive Care Med. 1994;20(suppl):S2-S6.
15. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27(5):887-892.
16. Leu HS, Kaiser DL, Mori M, et al. Hospital-acquired pneumonia: attributable mortality and morbidity. Am J Epidemiol. 1989;129:1258-1267.
17. Hubmayr RD. Statement of the Fourth International Consensus Conference in Critical Care on ICU-Acquired Pneumonia, Chicago, Illinois, May 2002. Intensive Care Med. 2002;28:1521-1536.
18. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture technique. Am Rev Respir Dis. 1989;139:877-884.
19. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognostic factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142:523-528.
20. Rello J, Quintana E, Ausina V, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest. 1991;100:439-444.
21. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520-532.
22. Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA analysis.JAMA. 1993;270:1965-1970.
23. Rello J, Diaz E, Roque M, et al. Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med. 1999;159:1742-1746.
24. Vincent JL, Bihari D, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: the results of the EPIC study. JAMA. 1995;274:639-644.
25. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21:510-515.
26. Papia G, McLellan BA, El Helou P, et al. Infection in hospitalized trauma patients: incidence, risk factors, and complications. J Trauma. 1999;47:923-927.
27. George DL, Falk PS, Wunderink RG, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med. 1998;158:1839-1847.
28. Chevret S, Hemmer M, Carlet J, et al. Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med. 1993;19:256-264.
29. Langer M, Mosconi P, Cigada M, et al. Long-term respiratory support and risk of pneumonia in critically ill patients: Intensive Care Unit Group of Infection Control. Am Rev Respir Dis. 1989;140:302-305.
30. Chastre J, Fagon JY, Domart Y, et al. Diagnosis of nosocomial pneumonia in intensive care unit patients. Eur J Clin Microbiol Infect Dis. 1989;8:35-39.
31. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433-440.
32. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281-288.
33. Fagon J-Y, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients. Am Rev Respir Dis. 1988;138:110-116.
34. Hoffken G, Niederman MS, Nosocomial pneumonia. The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002;122:2183-2196.
35. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122:2115-2121.
36. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med. 2003;31:2544-2551.
37. Bregeon F, Ciais V, Carret V, et al. Is ventilator-associated pneumonia an independent risk factor for death? Anesthesiology. 2001;94:554-560.
38. Rello J, Jubert P, Valles J, et al. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis. 1996;23:973-978.
39. Rello J, Torres A, Ricart M, et al. Ventilator associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant with methicillin sensitive episodes. Am J Respir Crit Care Med. 1994;150:1545-1549.
40. Fagon JY, Chastre J, Domart Y, et al. Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis. 1996;23:538-542.
41. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999;159:1249-1256.
42. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676-685.
43. Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196-200.
44. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group. Intensive Care Med. 1996;22:387-394.
45. Dreyfuss D, Djedaini K, Gros I, et al. Mechanical ventilation with heated humidifiers and heat moisture exchangers: effects on patient colonization and incidence of nosocomial pneumonia. Am J Respir Crit Care Med. 1995;151:986-992.
46. Torres A, Serra-Batlles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med. 1992;116:540-543.
47. Orozco-Levi M, Torres A, Ferrer M, et al. Semi-recumbent position protect from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med. 1995;152:1387-1390.
48. Vallés J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med. 1995;122: 229-231.
49. Rumbak MJ. Ventilator-associated pneumonia. J Respir Dis. 2000;21:321-327.
50. Ricart M. Management of airways in intubated patients. Clin Pulm Med. 1997;4:148-151.
51. Rello J, Soñora R, Jubert P, et al. Pneumonia in intubated patients: role of respiratory airway care. Am J Respir Crit Care Med. 1996;154:111-115.
52. Olson ME, Harmon BG, Kollef MH. Silvercoated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest. 2002;121:863-870.
53. Rouby JJ, Martin, De Lassale E, Poete P, et al. Nosocomial bronchopneumonia in the critically ill. Histologic and bacteriologic aspects. Am Rev Respir Dis. 1992;146:1059-1066.
54. Wunderink RG, Woldenberg LS, Zeiss J, et al. The radiologic diagnosis of autopsy proven ventilator-associated pneumonia. Chest. 1992;101:458-463.
55. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 1994;106:221-235.
56. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505-511.
57. Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701-706.
58. Torres A, Carlet J, and members of the Task Force. ERS task force on ventilator-associated pneumonia. Eur Respir J. 2001;17:1034-1045.
59. Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator-associated pneumonia revisited: comparative evaluation using immediate postmortem biopsies. Thorax. 1999;54:867-873.
60. Fagon J-Y, Chastre J, Hance AJ, Domart Y, Trouillet J-L, Gibert C. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest. 1993;103:547-553.
61. Mayhall CG. Ventilator-associated pneumonia or not? Contemporary diagnosis. Emerg Infect Dis. 2001;7(2):200-204.
62. Mayer J. Laboratory diagnosis of nosocomial pneumonia. Semin Respir Infect. 2000;15(2):119-131.
63. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator- associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121-1129.
64. Torres A, Ewig S. Diagnosing ventilator-associated pneumonia. N Engl J Med. 2004;350(5):433-435.
65. Gibot S, Cravoisy A, Levy B, Bene M-C, Faure G, Bollaert P-E. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350:451-458.
66. Spencer RC. Predominant pathogens found in the European prevalence of infection in intensive care study. Eur J Clin Microbiol Infect Dis. 1996;5:281-285.
67. Strausbaugh LJ. Nosocomial respiratory infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Churchill Livingston; 2000:3020-3028.
68. Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med. 1995;152:231-240.
69. Chastre J, Trouillet JL, Vuagnat A, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;157:1165-1172.
70. Dore P, Robert R, Grollier G, et al. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush. Am J Respir Crit Care Med. 1996;153:1292-1298.
71. Chastre J, Viau F, Brun P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis. 1984;130:924-929.
72. Kneeland YJ, Price KM. Antibiotics and terminal pneumonia. Am J Med. 1960;29:967-979.
73. Johanson WG Jr, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. N Engl J Med. 1969;281:1137-1140.
74. Denneson P, van der Ven A, Kessels A, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163:1371-1375.
75. Hung JB, Niederman MS. Early resolution of oxygenation defects predicts survival from nosocomial pneumonia [abstract]. Chest. 2000;118(suppl):112S.
76. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA. 1996;275:308-314.
77. Feldman C, Kassel M, Cantrell J, et al. The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilations. Eur Respir J. 1999;13(3):546-551.
78. Chulay M. Why do we keep putting saline down endotracheal tubes? It's time for a change in the way we suction! Capsules Comments Crit Care Nurs. 1994;2(4):7-11.
79. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med. 2002;346(22): 1715-1722.
80. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med. 1999;340(8):627-634.
81. Kunis KA, Puntillo KA. Ventilator-associated pneumonia in the ICU. AJN. 2003;103(8):64AA-64GG.
82. Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recommendations Rep. 1997;46(RR-1):1-79.
83. Shorr AF, O'Malley PG. Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia: potential economic implications. Chest. 2001;119(1):228-235.
84. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomized trial. Lancet. 1999;354(9193):1851-1858.
85. Collard HR, Saint S, Matthay MA. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 2003;138:494-501.
86. Zack JE, Garrison T, Trovillion E, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med. 2002;30(11)::2407-2412.
87. Cross JT Jr, Campbell GD Jr. Therapy of nosocomial pneumonia. Med Clin North Am. 2001;85(6):1583-1594.
88. Cunha BA. Nosocomial pneumonia. Diagnostic and therapeutic considerations Med Clin North Am. 2001;85(1):79-114.
89. Beck K-D, Gastmeier P. Clinical or epidemiologic diagnosis of nosocomial pneumonia: is there any difference? AJIC. 2003;31(6):331-335.
90. Chastre J, Wolff M, Fagon JY, et al, and the Pneum A Trial Group. Comparison of 8- vs. 15-days of antibiotic therapy for ventilator associated pneumonia in adults. JAMA. 2003;290(19):2588-2598.
91. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis. 2000;31:383-421.